Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
01 1Aarti Pharmalabs Limited
02 1B.V. KATWIJK CHEMIE
01 1DEFERIPRONE
02 1Deferiprone
01 1India
02 1Netherlands
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-2908
Start Marketing Date : 2023-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (360kg/360kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17349-0023
Start Marketing Date : 2018-03-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Deferiprone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferiprone, including repackagers and relabelers. The FDA regulates Deferiprone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferiprone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferiprone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferiprone supplier is an individual or a company that provides Deferiprone active pharmaceutical ingredient (API) or Deferiprone finished formulations upon request. The Deferiprone suppliers may include Deferiprone API manufacturers, exporters, distributors and traders.
click here to find a list of Deferiprone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deferiprone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deferiprone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deferiprone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deferiprone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deferiprone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deferiprone suppliers with NDC on PharmaCompass.
We have 2 companies offering Deferiprone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
